A study looking at helping women stay on hormone therapy after breast cancer (SWEET)

This study is looking at a support package to help women to continue taking their hormone therapy after having breast surgery. The team hope that use of the support package will help women to keep taking their hormone therapy as recommended by their doctors, and improve their wellbeing (quality of life).

It is open to women who have oestrogen receptor positive (ER positive) breast cancer and have been prescribed:

• tamoxifen

• letrozole

• anastrozole

• exemestane

• any other aromatase inhibitor